Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma
Vinorelbine (Navelbine, VRL) is commonly used for platinum-resistant ovarian cancer and has been shown to be effective in patients with recurrent primary peritoneal carcinoma. Of VRL's major side effects, skin rash is uncommon, and, if it does occur, it is usually localized to site of injection...
Saved in:
Main Authors: | Mustafa M. Mohammad (Author), Kostas N. Syrigos (Author), M. Wasif Saif (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case Report of Rash at Peritoneal Dialysis Exit Site
by: Elvira O. Gosmanova MD, FASN, et al.
Published: (2015) -
Lamotrigine-Associated Skin Rash
by: J Gordon Millichap
Published: (1999) -
Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study
by: Yoshihito Morimoto, et al.
Published: (2018) -
Effect of surface modification on the In vitro protein adsorption and cell cytotoxicity of vinorelbine nanoparticles
by: Nandhakumar Sathyamoorthy, et al.
Published: (2017) -
Not a drug rash!
by: Ananta Khurana, et al.
Published: (2020)